| Literature DB >> 34345320 |
Kaitlyn E Watson1, Ross T Tsuyuki1, Nathan P Beahm2, Rebecca Sedore3, Alan Bell4.
Abstract
BACKGROUND: The uptake of clinical practice guidelines into practice is limited for many chronic conditions, including hypertension. The aim of this study was to ascertain the importance of the educational competencies for the development of the Hypertension Canada Professional Certification Program (HC-PCP) among frontline, primary care professionals (e.g., pharmacists, physicians, nurses).Entities:
Year: 2021 PMID: 34345320 PMCID: PMC8282914 DOI: 10.1177/17151635211016493
Source DB: PubMed Journal: Can Pharm J (Ott) ISSN: 1715-1635
Participant responses to the 15 potential competencies
| Competencies ( | Mean (SD) | Not important, | Neutral, | Important, | Very important, |
|---|---|---|---|---|---|
| 1. Demonstrates a sound knowledge of the epidemiology of hypertension. | 4.07 (0.85) | 6 (5) | 28 (23.1) | 38 (31.4) | 49 (40.5) |
| 2. Demonstrates a substantial understanding of the pathophysiology of hypertension. | 4.42 (0.075) | 5 (4.1) | 8 (6.6) | 38 (31.4) | 70 (57.9) |
| 3. Is knowledgeable in hypertension prevention strategies. | 4.79 (0.043) | 0 | 3 (2.5) | 20 (16.5) | 98 (81) |
| 4. Is able to demonstrate the proper technique when measuring blood pressure. | 4.77 (0.045) | 0 | 4 (3.3) | 20 (16.5) | 97 (80.2) |
| 5. Demonstrates an understanding of the validation process for blood pressure devices. | 4.15 (0.08) | 3 (2.5) | 27 (22.3) | 39 (32.2) | 52 (43) |
| 6. Demonstrates an ability to screen for and identify individual patient cases for hypertension. | 4.83 (0.04) | 0 | 3 (2.5) | 15 (12.4) | 103 (85.1) |
| 7. Demonstrates the ability to appropriately diagnose hypertension. | 4.81 (0.043) | 0 | 4 (3.3) | 15 (12.4) | 102 (84.3) |
| 8. Demonstrate a knowledge of common comorbidities in hypertension and how they affect diagnosis and management. | 4.74 (0.049) | 1 (0.8) | 3 (2.5) | 23 (19) | 94 (77.7) |
| 9. Demonstrates the ability to assess risk factors for cardiovascular disease and calculate a risk score for cardiovascular events. | 4.74 (0.043) | 0 | 2 (1.7) | 27 (22.3) | 92 (76) |
| 10. Demonstrate a knowledge of the end-organ effects of hypertension and how it is identified and prevented. | 4.75 (0.043) | 0 | 2 (1.7) | 26 (21.5) | 93 (76.9) |
| 11. Has a working knowledge of diet and lifestyle measures for hypertension. | 4.69 (0.048) | 0 | 4 (3.3) | 29 (24) | 88 (72.7) |
| 12. Demonstrates exemplary decision-making with respect to the pharmacologic management of hypertension. | 4.72 (0.047) | 0 | 4 (3.3) | 26 (21.5) | 91 (75.2) |
| 13. Can identify adherence support strategies for antihypertensive therapy. | 4.6 (0.055) | 0 | 7 (5.8) | 35 (28.9) | 79 (65.3) |
| 14. Can implement appropriate follow-up strategies. | 4.57 (0.057) | 0 | 9 (7.4) | 34 (28.1) | 78 (64.5) |
| 15. Is able to identify patients who require referral to other health care professionals (e.g., specialists). | 4.64 (0.055) | 0 | 8 (6.6) | 28 (23.1) | 85 (70.2) |
Figure 1Hypertension Canada Professional Certification Program course outline with the mapped competencies and Hypertension Canada guidelines